{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T10:15:26Z","timestamp":1774865726333,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T00:00:00Z","timestamp":1602633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T00:00:00Z","timestamp":1602633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005297","name":"Uniwersytet Medyczny w Bialymstoku","doi-asserted-by":"crossref","award":["N\/ST\/ZB\/16\/001\/1126"],"award-info":[{"award-number":["N\/ST\/ZB\/16\/001\/1126"]}],"id":[{"id":"10.13039\/501100005297","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Purpose<\/jats:title><jats:p>Familial hypercholesterolemia (FH) requires early treatment. However, statins, which are regarded the first-line therapy, have an influence on redox balance. Antioxidant vitamins are important for many metabolic processes in the developing body. There are few data available on the long-term safety of statin use in children. The aim of this study was to evaluate the influence of statin treatment in children with FH on plasma concentrations of antioxidant vitamins: retinol, alpha-tocopherol and coenzyme Q10.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The first study group consisted of 13 children aged 10\u201318\u00a0years treated with simvastatin for at least 6\u00a0months, and the second group comprised 13 age- and sex-matched children with hypercholesterolemia, in whom pharmacological treatment had not been applied yet. Analyses were performed using a high-performance liquid chromatograph coupled with a MS detector.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The analysis did not reveal significant differences in the concentration of retinol, alpha-tocopherol or coenzyme Q10 between the studied groups. The adjustment of the concentrations of the vitamins to the cholesterol level also indicated no significant differences. We found no deficits in antioxidant vitamins in patients treated with statins, or any risk of adverse effects associated with an increase in their concentration.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>There is no rationale for additional supplementation using antioxidant vitamins or modification of low-fat and low-cholesterol diet in pediatric patients treated with statins.<\/jats:p><\/jats:sec>","DOI":"10.1007\/s10557-020-07091-w","type":"journal-article","created":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T10:03:19Z","timestamp":1602669799000},"page":"75-84","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Effect of Statin Therapy on the Plasma Concentrations of Retinol, Alpha-Tocopherol and Coenzyme Q10 in Children with Familial Hypercholesterolemia"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8735-2783","authenticated-orcid":false,"given":"Rados\u0142aw","family":"Motkowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mateusz","family":"Maciejczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Hryniewicka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Karpi\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo\u017cena","family":"Miko\u0142u\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,14]]},"reference":[{"issue":"20","key":"7091_CR1","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1093\/eurheartj\/ehx136","volume":"38","author":"BG Nordestgaard","year":"2017","unstructured":"Nordestgaard BG, Benn M. Genetic testing for familial hypercholesterolaemia is essential in individuals with high LDL cholesterol: who does it in the world? Eur Heart J. 2017;38(20):1580\u20133.","journal-title":"Eur Heart J"},{"issue":"10","key":"7091_CR2","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.5603\/KP.2013.0276","volume":"71","author":"M Mysliwiec","year":"2013","unstructured":"Mysliwiec M, Walczak M, Malecka-Tendera E, Dobrzanska A, Cybulska B, Filipiak KJ, et al. Management in familial hypercholesterolaemia in children and adolescents. Position of the lipid expert forum. Kardiol Pol. 2013;71(10):1099\u2013105.","journal-title":"Kardiol Pol"},{"issue":"3 Suppl","key":"7091_CR3","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jacl.2011.04.003","volume":"5","author":"AC Goldberg","year":"2011","unstructured":"Goldberg AC, Hopkins PN, Toth PP, Ballantyne CM, Rader DJ, Robinson JG, et al. Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on familial hypercholesterolemia. J Clin Lipidol. 2011;5(3 Suppl):S1\u20138.","journal-title":"J Clin Lipidol."},{"issue":"25","key":"7091_CR4","first-page":"e1082","volume":"139","author":"SM Grundy","year":"2018","unstructured":"Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2019. 2018;139(25):e1082\u2013e143.","journal-title":"Circulation 2019"},{"issue":"4","key":"7091_CR5","doi-asserted-by":"crossref","first-page":"479","DOI":"10.4158\/EP171764.GL","volume":"23","author":"PS Jellinger","year":"2017","unstructured":"Jellinger PS, Handelsman Y, Rosenblit PD, Bloomgarden ZT, Fonseca VA, Garber AJ, et al. American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease - executive Summary. Complete appendix to guidelines available at http:\/\/journals.aace.com. Endocr Pract. 2017;23(4):479\u201397.","journal-title":"Endocr Pract"},{"key":"7091_CR6","doi-asserted-by":"crossref","unstructured":"Barringer TA. 3rd. WOSCOPS. West of Scotland Coronary Prevention Group Lancet 1997;349(9049):432\u20133.","DOI":"10.1016\/S0140-6736(97)80057-8"},{"issue":"19","key":"7091_CR7","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","volume":"339","author":"Long-Term Intervention with Pravastatin in Ischaemic Disease Study G","year":"1998","unstructured":"Long-Term Intervention with Pravastatin in Ischaemic Disease Study G. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med. 1998;339(19):1349\u201357.","journal-title":"N Engl J Med"},{"issue":"21","key":"7091_CR8","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","volume":"359","author":"PM Ridker","year":"2008","unstructured":"Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359(21):2195\u2013207.","journal-title":"N Engl J Med"},{"issue":"10059","key":"7091_CR9","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/S0140-6736(16)31357-5","volume":"388","author":"R Collins","year":"2016","unstructured":"Collins R, Reith C, Emberson J, Armitage J, Baigent C, Blackwell L, et al. Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet. 2016;388(10059):2532\u201361.","journal-title":"Lancet."},{"issue":"2","key":"7091_CR10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1586\/17512433.2015.1011125","volume":"8","author":"H Okuyama","year":"2015","unstructured":"Okuyama H, Langsjoen PH, Hamazaki T, Ogushi Y, Hama R, Kobayashi T, et al. Statins stimulate atherosclerosis and heart failure: pharmacological mechanisms. Expert Rev Clin Pharmacol. 2015;8(2):189\u201399.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"7091_CR11","first-page":"CD006401","volume":"7","author":"A Vuorio","year":"2017","unstructured":"Vuorio A, Kuoppala J, Kovanen PT, Humphries SE, Tonstad S, Wiegman A, et al. Statins for children with familial hypercholesterolemia. Cochrane Database Syst Rev. 2017;7:CD006401.","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"7091_CR12","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1161\/CIRCULATIONAHA.106.671016","volume":"116","author":"J Rodenburg","year":"2007","unstructured":"Rodenburg J, Vissers MN, Wiegman A, van Trotsenburg AS, van der Graaf A, de Groot E, et al. Statin treatment in children with familial hypercholesterolemia: the younger, the better. Circulation. 2007;116(6):664\u20138.","journal-title":"Circulation."},{"issue":"1","key":"7091_CR13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jacl.2017.11.005","volume":"12","author":"SE Humphries","year":"2018","unstructured":"Humphries SE, Cooper J, Dale P, Ramaswami U, Group FHPRS. The UK Paediatric Familial Hypercholesterolaemia register: statin-related safety and 1-year growth data. J Clin Lipidol. 2018;12(1):25\u201332.","journal-title":"J Clin Lipidol"},{"issue":"4","key":"7091_CR14","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.bbrc.2010.02.071","volume":"393","author":"JM Gutteridge","year":"2010","unstructured":"Gutteridge JM, Halliwell B. Antioxidants: molecules, medicines, and myths. Biochem Biophys Res Commun. 2010;393(4):561\u20134.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"7091_CR15","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3390\/jcm3020453","volume":"3","author":"W Chen","year":"2014","unstructured":"Chen W, Chen G. The roles of vitamin A in the regulation of carbohydrate, lipid, and protein metabolism. J Clin Med. 2014;3(2):453\u201379.","journal-title":"J Clin Med"},{"issue":"19","key":"7091_CR16","doi-asserted-by":"crossref","first-page":"13001","DOI":"10.1074\/jbc.R500027200","volume":"281","author":"M Liden","year":"2006","unstructured":"Liden M, Eriksson U. Understanding retinol metabolism: structure and function of retinol dehydrogenases. J Biol Chem. 2006;281(19):13001\u20134.","journal-title":"J Biol Chem"},{"issue":"2","key":"7091_CR17","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/ajcn\/83.2.191","volume":"83","author":"KL Penniston","year":"2006","unstructured":"Penniston KL, Tanumihardjo SA. The acute and chronic toxic effects of vitamin a. Am J Clin Nutr. 2006;83(2):191\u2013201.","journal-title":"Am J Clin Nutr"},{"issue":"7049","key":"7091_CR18","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature03711","volume":"436","author":"Q Yang","year":"2005","unstructured":"Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature. 2005;436(7049):356\u201362.","journal-title":"Nature"},{"issue":"14","key":"7091_CR19","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1161\/CIRCULATIONAHA.116.024503","volume":"135","author":"Y Liu","year":"2017","unstructured":"Liu Y, Zhong Y, Chen H, Wang D, Wang M, Ou JS, et al. Retinol-binding protein-dependent cholesterol uptake regulates macrophage foam cell formation and promotes atherosclerosis. Circulation. 2017;135(14):1339\u201354.","journal-title":"Circulation"},{"issue":"Suppl","key":"7091_CR20","doi-asserted-by":"crossref","first-page":"s57","DOI":"10.1016\/0098-2997(94)90013-2","volume":"15","author":"A Constantinescu","year":"1994","unstructured":"Constantinescu A, Maguire JJ, Packer L. Interactions between ubiquinones and vitamins in membranes and cells. Mol Asp Med. 1994;15(Suppl):s57\u201365.","journal-title":"Mol Asp Med"},{"issue":"3","key":"7091_CR21","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF02592449","volume":"24","author":"AM Bargossi","year":"1994","unstructured":"Bargossi AM, Battino M, Gaddi A, Fiorella PL, Grossi G, Barozzi G, et al. Exogenous CoQ10 preserves plasma ubiquinone levels in patients treated with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Int J Clin Lab Res. 1994;24(3):171\u20136.","journal-title":"Int J Clin Lab Res"},{"issue":"8","key":"7091_CR22","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.bbabio.2016.03.036","volume":"1857","author":"MJ Acosta","year":"2016","unstructured":"Acosta MJ, Vazquez Fonseca L, Desbats MA, Cerqua C, Zordan R, Trevisson E, et al. Coenzyme Q biosynthesis in health and disease. Biochim Biophys Acta. 2016;1857(8):1079\u201385.","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"7091_CR23","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0735-1097(03)00082-2","volume":"41","author":"AM Gotto","year":"2003","unstructured":"Gotto AM. Antioxidants, statins, and atherosclerosis. J Am Coll Cardiol. 2003;41(7):1205\u201310.","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"7091_CR24","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1001\/archinte.159.12.1279","volume":"159","author":"GA Ewy","year":"1999","unstructured":"Ewy GA. Antioxidant therapy for coronary artery disease: don't paint the walls without treating the termites! Arch Intern Med. 1999;159(12):1279\u201380.","journal-title":"Arch Intern Med"},{"issue":"12","key":"7091_CR25","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1001\/archinte.159.12.1313","volume":"159","author":"AP Spencer","year":"1999","unstructured":"Spencer AP, Carson DS, Crouch MA. Vitamin E and coronary artery disease. Arch Intern Med. 1999;159(12):1313\u201320.","journal-title":"Arch Intern Med"},{"issue":"15","key":"7091_CR26","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJM199404143301501","volume":"330","author":"The Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group","year":"1994","unstructured":"The Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med. 1994;330(15):1029\u201335.","journal-title":"N Engl J Med"},{"issue":"18","key":"7091_CR27","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1056\/NEJM199605023341802","volume":"334","author":"GS Omenn","year":"1996","unstructured":"Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, et al. Effects of a combination of beta carotene and vitamin a on lung cancer and cardiovascular disease. N Engl J Med. 1996;334(18):1150\u20135.","journal-title":"N Engl J Med"},{"issue":"9326","key":"7091_CR28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(02)09328-5","volume":"360","author":"Heart Protection Study Collaborative Group","year":"2002","unstructured":"Heart Protection Study Collaborative Group. MRC\/BHF heart protection study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360(9326):23\u201333.","journal-title":"Lancet"},{"issue":"16","key":"7091_CR29","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa1816454","volume":"381","author":"IK Luirink","year":"2019","unstructured":"Luirink IK, Wiegman A, Kusters DM, Hof MH, Groothoff JW, de Groot E, et al. 20-year follow-up of statins in children with familial hypercholesterolemia. N Engl J Med. 2019;381(16):1547\u201356.","journal-title":"N Engl J Med"},{"key":"7091_CR30","doi-asserted-by":"crossref","unstructured":"Expert Panel on Integrated Guidelines for Cardiovascular H, Risk Reduction in C, Adolescents, National Heart L, Blood I. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011;128 Suppl 5:S213\u201356.","DOI":"10.1542\/peds.2009-2107C"},{"issue":"2","key":"7091_CR31","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jpba.2006.03.037","volume":"42","author":"J Karpinska","year":"2006","unstructured":"Karpinska J, Mikoluc B, Motkowski R, Piotrowska-Jastrzebska J. HPLC method for simultaneous determination of retinol, alpha-tocopherol and coenzyme Q10 in human plasma. J Pharm Biomed Anal. 2006;42(2):232\u20136.","journal-title":"J Pharm Biomed Anal"},{"issue":"2","key":"7091_CR32","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0022-3476(97)70354-8","volume":"130","author":"S Tonstad","year":"1997","unstructured":"Tonstad S, Aksnes L. Fat-soluble vitamin levels in familial hypercholesterolemia. J Pediatr. 1997;130(2):274\u201380.","journal-title":"J Pediatr"},{"issue":"5","key":"7091_CR33","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/ajcn\/54.5.884","volume":"54","author":"B Herbeth","year":"1991","unstructured":"Herbeth B, Spyckerelle Y, Deschamps JP. Determinants of plasma retinol, beta-carotene, and alpha-tocopherol during adolescence. Am J Clin Nutr. 1991;54(5):884\u20139.","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"7091_CR34","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ijcard.2006.03.089","volume":"118","author":"MJ Shin","year":"2007","unstructured":"Shin MJ, Chung N, Lee JH, Jang Y, Park E, Jeon KI, et al. Effects of simvastatin on plasma antioxidant status and vitamins in hypercholesterolemic patients. Int J Cardiol. 2007;118(2):173\u20137.","journal-title":"Int J Cardiol"},{"issue":"2","key":"7091_CR35","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.atherosclerosis.2015.09.028","volume":"243","author":"A Sahebkar","year":"2015","unstructured":"Sahebkar A, Simental-Mendia LE, Ferretti G, Bacchetti T, Golledge J. Statin therapy and plasma vitamin E concentrations: a systematic review and meta-analysis of randomized placebo-controlled trials. Atherosclerosis. 2015;243(2):579\u201388.","journal-title":"Atherosclerosis"},{"issue":"4","key":"7091_CR36","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-2362.2005.01486.x","volume":"35","author":"DM Colquhoun","year":"2005","unstructured":"Colquhoun DM, Jackson R, Walters M, Hicks BJ, Goldsmith J, Young P, et al. Effects of simvastatin on blood lipids, vitamin E, coenzyme Q10 levels and left ventricular function in humans. Eur J Clin Investig. 2005;35(4):251\u20138.","journal-title":"Eur J Clin Investig"},{"issue":"9","key":"7091_CR37","doi-asserted-by":"crossref","first-page":"34C","DOI":"10.1016\/S0002-9149(99)80468-8","volume":"76","author":"R Salonen","year":"1995","unstructured":"Salonen R, Nyssonen K, Porkkala-Sarataho E, Salonen JT. The Kuopio atherosclerosis prevention study (KAPS): effect of pravastatin treatment on lipids, oxidation resistance of lipoproteins, and atherosclerotic progression. Am J Cardiol. 1995;76(9):34C\u20139C.","journal-title":"Am J Cardiol"},{"issue":"2","key":"7091_CR38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/jama.281.2.137","volume":"281","author":"EA Stein","year":"1999","unstructured":"Stein EA, Illingworth DR, Kwiterovich PO Jr, Liacouras CA, Siimes MA, Jacobson MS, et al. Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlled trial. JAMA. 1999;281(2):137\u201344.","journal-title":"JAMA"},{"issue":"8","key":"7091_CR39","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1080\/07853890410018844","volume":"36","author":"T Vasankari","year":"2004","unstructured":"Vasankari T, Ahotupa M, Viikari J, Nuotio I, Strandberg T, Vanhanen H, et al. Effect of 12-month statin therapy on antioxidant potential of LDL and serum antioxidant vitamin concentrations. Ann Med. 2004;36(8):618\u201322.","journal-title":"Ann Med"},{"issue":"5","key":"7091_CR40","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1194\/jlr.M800647-JLR200","volume":"50","author":"JY Cho","year":"2009","unstructured":"Cho JY, Kang DW, Ma X, Ahn SH, Krausz KW, Luecke H, et al. Metabolomics reveals a novel vitamin E metabolite and attenuated vitamin E metabolism upon PXR activation. J Lipid Res. 2009;50(5):924\u201337.","journal-title":"J Lipid Res"},{"issue":"5","key":"7091_CR41","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1111\/j.1476-5381.2011.01665.x","volume":"165","author":"E Hoffart","year":"2012","unstructured":"Hoffart E, Ghebreghiorghis L, Nussler AK, Thasler WE, Weiss TS, Schwab M, et al. Effects of atorvastatin metabolites on induction of drug-metabolizing enzymes and membrane transporters through human pregnane X receptor. Br J Pharmacol. 2012;165(5):1595\u2013608.","journal-title":"Br J Pharmacol"},{"issue":"5\u20136","key":"7091_CR42","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1024\/0300-9831\/a000281","volume":"85","author":"S Peter","year":"2015","unstructured":"Peter S, Friedel A, Roos FF, Wyss A, Eggersdorfer M, Hoffmann K, et al. A systematic review of global Alpha-Tocopherol status as assessed by nutritional intake levels and blood serum concentrations. Int J Vitam Nutr Res. 2015;85(5\u20136):261\u201381.","journal-title":"Int J Vitam Nutr Res"},{"key":"7091_CR43","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.phrs.2015.07.008","volume":"99","author":"M Banach","year":"2015","unstructured":"Banach M, Serban C, Ursoniu S, Rysz J, Muntner P, Toth PP, et al. Statin therapy and plasma coenzyme Q10 concentrations--a systematic review and meta-analysis of placebo-controlled trials. Pharmacol Res. 2015;99:329\u201336.","journal-title":"Pharmacol Res"},{"issue":"1","key":"7091_CR44","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1080\/15376510802305047","volume":"19","author":"AJ Duncan","year":"2009","unstructured":"Duncan AJ, Hargreaves IP, Damian MS, Land JM, Heales SJ. Decreased ubiquinone availability and impaired mitochondrial cytochrome oxidase activity associated with statin treatment. Toxicol Mech Methods. 2009;19(1):44\u201350.","journal-title":"Toxicol Mech Methods"},{"issue":"11","key":"7091_CR45","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1001\/archneur.62.11.1709","volume":"62","author":"C Lamperti","year":"2005","unstructured":"Lamperti C, Naini AB, Lucchini V, Prelle A, Bresolin N, Moggio M, et al. Muscle coenzyme Q10 level in statin-related myopathy. Arch Neurol. 2005;62(11):1709\u201312.","journal-title":"Arch Neurol"},{"issue":"6","key":"7091_CR46","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11883-018-0730-1","volume":"20","author":"J Ayers","year":"2018","unstructured":"Ayers J, Cook J, Koenig RA, Sisson EM, Dixon DL. Recent developments in the role of coenzyme Q10 for coronary heart disease: a systematic review. Curr Atheroscler Rep. 2018;20(6):29.","journal-title":"Curr Atheroscler Rep"},{"issue":"6","key":"7091_CR47","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10557-005-5686-z","volume":"19","author":"E Bruckert","year":"2005","unstructured":"Bruckert E, Hayem G, Dejager S, Yau C, Begaud B. Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study. Cardiovasc Drugs Ther. 2005;19(6):403\u201314.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"19","key":"7091_CR48","doi-asserted-by":"crossref","first-page":"e009835","DOI":"10.1161\/JAHA.118.009835","volume":"7","author":"H Qu","year":"2018","unstructured":"Qu H, Guo M, Chai H, Wang WT, Gao ZY, Shi DZ. Effects of coenzyme Q10 on statin-induced myopathy: an updated meta-analysis of randomized controlled trials. J Am Heart Assoc. 2018;7(19):e009835.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"7091_CR49","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0891-5849(02)00863-8","volume":"33","author":"B Wittenstein","year":"2002","unstructured":"Wittenstein B, Klein M, Finckh B, Ullrich K, Kohlschutter A. Plasma antioxidants in pediatric patients with glycogen storage disease, diabetes mellitus, and hypercholesterolemia. Free Radic Biol Med. 2002;33(1):103\u201310.","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"7091_CR50","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jpeds.2010.08.015","volume":"158","author":"HJ Avis","year":"2011","unstructured":"Avis HJ, Hargreaves IP, Ruiter JP, Land JM, Wanders RJ, Wijburg FA. Rosuvastatin lowers coenzyme Q10 levels, but not mitochondrial adenosine triphosphate synthesis, in children with familial hypercholesterolemia. J Pediatr. 2011;158(3):458\u201362.","journal-title":"J Pediatr"},{"issue":"2","key":"7091_CR51","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jped.2017.12.005","volume":"95","author":"UM Alkholy","year":"2019","unstructured":"Alkholy UM, Abdalmonem N, Zaki A, Elkoumi MA, Hashim MIA, Basset MAA, et al. The antioxidant status of coenzyme Q10 and vitamin E in children with type 1 diabetes. J Pediatr. 2019;95(2):224\u201330.","journal-title":"J Pediatr"},{"issue":"6","key":"7091_CR52","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1161\/01.CIR.99.6.779","volume":"99","author":"M de Lorgeril","year":"1999","unstructured":"de Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon diet heart study. Circulation. 1999;99(6):779\u201385.","journal-title":"Circulation"},{"issue":"8663","key":"7091_CR53","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0140-6736(89)90710-1","volume":"2","author":"DJ Barker","year":"1989","unstructured":"Barker DJ, Winter PD, Osmond C, Margetts B, Simmonds SJ. Weight in infancy and death from ischaemic heart disease. Lancet. 1989;2(8663):577\u201380.","journal-title":"Lancet."},{"issue":"2","key":"7091_CR54","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1093\/ajcn\/71.2.602","volume":"71","author":"A Lucas","year":"2000","unstructured":"Lucas A. Programming not metabolic imprinting. Am J Clin Nutr. 2000;71(2):602.","journal-title":"Am J Clin Nutr"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-020-07091-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-020-07091-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-020-07091-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T06:40:23Z","timestamp":1669185623000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-020-07091-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,14]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["7091"],"URL":"https:\/\/doi.org\/10.1007\/s10557-020-07091-w","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,14]]},"assertion":[{"value":"2 October 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study was performed in line with principles of the Declaration of Helsinki. The protocol was approved by the Bioethics Committee at the Medical University of Bialystok.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The parents of the children included in the study gave their informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate and for Publication"}}]}}